Status:

COMPLETED

TENS Treatment for Bedwetting

Lead Sponsor:

Albany Medical College

Conditions:

Nocturnal Enuresis

Bed Wetting

Eligibility:

All Genders

5-18 years

Phase:

NA

Brief Summary

Children referred to pediatric urology clinic for primary nocturnal enuresis will be screened for enrollment. Patients who fail will next be offered therapy with a bedwetting alarm device or a TENS un...

Detailed Description

Institutional review board approval was obtained. Children ages 5-18 years old referred to the pediatric urology clinic for primary nocturnal enuresis will be screened for enrollment. Behavioral modif...

Eligibility Criteria

Inclusion

  • Presenting with nocturnal enuresis (more than 1x a week)
  • Failed Behavioral modification treatment (limiting evening drinking, double voiding prior to bedtime, bowel habits, social anxiety factors)
  • Ability to provide informed consent and assent and complete study requirements

Exclusion

  • Patients who have previously tried pharmacologic treatment for nocturnal enuresis, neuromodulation or other alternative therapy for urologic disorders within the past 30 days
  • Daytime incontinence symptoms
  • Known "high volume" voiders (determined from history)
  • Bedwetting episodes on the average of less than two times per week,
  • Medications predisposing to incontinence (eg, Lithium for bipolar disorder)
  • Other known voiding or neurologic disorders (eg, overactive bladder, myelomeningocele, interstitial cystitis, etc)
  • Secondary etiologies for nocturnal enuresis (eg, cystitis, obstructive sleep apnea, urinary fistulae, heart disease)
  • Any contraindications to usage of a TENS unit (pacemaker or other implantable device, lymphedema, pregnancy, malignancy,bleeding or clotting disorders, unhealthy tissue, seizure disorders, impaired cognition)
  • Any history of heart disease or complications

Key Trial Info

Start Date :

January 20 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2024

Estimated Enrollment :

125 Patients enrolled

Trial Details

Trial ID

NCT04313192

Start Date

January 20 2020

End Date

December 1 2024

Last Update

October 2 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Albany Medical College

Albany, New York, United States, 12208